Delving into the Latest Updates on Ferring Pharmaceuticals Korea Co., Ltd. with Synapse

Treatment patterns and clinical outcomes of Recombinant Follicle Stimulating Hormone in South Korean patients who received Controlled Ovarian Hyper-stimulation: Results from a retrospective observational chart review study

开始日期2019-08-20

申办/合作机构

Ferring Pharmaceuticals Korea Co., Ltd.

KCT0001223 / RecruitingN/A

The effect of minirin® on sleeping and voiding pattern to whom circadian rhythmic changed work-shift nurses

开始日期2014-04-28

申办/合作机构

Ferring Pharmaceuticals Korea Co., Ltd.

NCT01215513 / Completed临床3期

An Open-Label, Multi-Centre, Extension Trial, Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Dosing Regimen in Korean Patients Requiring Androgen Ablation Therapy

This is an open-label, multi-centre single arm trial to investigate long-term safety and tolerability of degarelix in Korean patients with prostate cancer.

开始日期2010-09-01

申办/合作机构

Ferring Pharmaceuticals A/S

[+1]

100 项与 Ferring Pharmaceuticals Korea Co., Ltd. 相关的临床结果

登录后查看更多信息

0 项与 Ferring Pharmaceuticals Korea Co., Ltd. 相关的专利（医药）

登录后查看更多信息

100 项与 Ferring Pharmaceuticals Korea Co., Ltd. 相关的药物交易

登录后查看更多信息

100 项与 Ferring Pharmaceuticals Korea Co., Ltd. 相关的转化医学

登录后查看更多信息